Early Detection of Neuroblastoma Recurrence on 18F mFBG PET
Authors:
- 9 February 2026
- journal article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (7) , 580-582
Abstract
A patient with neuroblastoma was assessed to be in remission based on clinical and standard-of-care imaging assessments, including a negative I-123 m IBG scan. Patient underwent 18 F m FBG PET/CT imaging on the same day as I-123 m IBG scan as part of a clinical trial (NCT: 04724369), which showed abnormal focal uptake suspicious for lesion in the skull. Patient underwent surveillance and follow-up with standard imaging. I-123 m IBG SPECT/CT at 3 months showed no abnormalities in the skull, but repeat examination at 6 months showed positive uptake corresponding to 18 F m FBG. Recurrent neuroblastoma was confirmed on MRI. This example indicates that 18 F m FBG PET identified neuroblastoma recurrence 6 months earlier than the current standard-of-care imaging.Keywords
This publication has 8 references indexed in Scilit:
- Lesion Analysis of 18F-Metafluorobenzylguanidine PET Imaging in NeuroblastomaJournal of Nuclear Medicine, 2025
- Performing [18F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with NeuroblastomaJournal of Nuclear Medicine, 2024
- [18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- [18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- [18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine MalignanciesJournal of Nuclear Medicine, 2017
- Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporterEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- NeuroblastomaThe Lancet, 2007